CLINICAL CASE OF CANAKINUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
The article presents a case of successful use of therapeutic monoclonal antibodies to interleukin 1 (canakinumab) at severe systemic juvenile idiopathic arthritis. Canakinumab treatment promptly provided reduction in clinical and laboratory disease activity indicators, increase in life quality, deve...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Paediatrician Publishers, LLC
2013-09-01
|
| Series: | Pediatričeskaâ Farmakologiâ |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/187 |